Abstract Whole genome duplication is frequently observed in cancer. and its prevalence in our prior analysis of end-stage. homologous recombination deficient high grade serous ovarian cancer (almost 80% of samples) supports the notion that whole genome duplication provides a fitness advantage under the selection pressure of therapy. Here. https://foldlyers.shop/product-category/trimmer/